CytoDyn (CYDY) Return on Capital Employed Growth (1y) (2012 - 2026)
CytoDyn (CYDY) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | 2,400.00 |
| 10 | CytoDyn | 261.29 Mn | 261.29 Mn | - | 12,054.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 12,054.00 |
| Nov 30, 2025 | 6,796.00 |
| Aug 31, 2025 | 5,102.00 |
| May 31, 2025 | -4,356.00 |
| Feb 28, 2025 | -2,973.00 |
| Nov 30, 2024 | -3,361.00 |
| Aug 31, 2024 | -4,826.00 |
| May 31, 2024 | -1,341.00 |
| Feb 29, 2024 | -9,216.00 |
| Nov 30, 2023 | -11,116.00 |
| Aug 31, 2023 | -11,244.00 |
| May 31, 2023 | -19,834.00 |
| Feb 28, 2023 | -41,844.00 |
| Nov 30, 2022 | -75,077.00 |
| Aug 31, 2022 | -76,169.00 |
| May 31, 2022 | -11,576.00 |
| Feb 28, 2022 | -7.05 Mn |
| Nov 30, 2021 | 440,573.00 |
| Aug 31, 2021 | -104,796.00 |
| May 31, 2021 | 4.56 Mn |